Clinical and molecular genetics of the phosphodiesterases (PDEs)
Cyclic nucleotide phosphodiesterases (PDEs) are enzymes that have the unique function of
terminating cyclic nucleotide signaling by catalyzing the hydrolysis of cAMP and GMP. They …
terminating cyclic nucleotide signaling by catalyzing the hydrolysis of cAMP and GMP. They …
Guanylyl cyclase structure, function and regulation
LR Potter - Cellular signalling, 2011 - Elsevier
Nitric oxide, bicarbonate, natriuretic peptides (ANP, BNP and CNP), guanylins, uroguanylins
and guanylyl cyclase activating proteins (GCAPs) activate a family of enzymes variously …
and guanylyl cyclase activating proteins (GCAPs) activate a family of enzymes variously …
The role of cyclic nucleotide signaling pathways in cancer: targets for prevention and treatment
AM Fajardo, GA Piazza, HN Tinsley - Cancers, 2014 - mdpi.com
For more than four decades, the cyclic nucleotides cyclic AMP (cAMP) and cyclic GMP
(cGMP) have been recognized as important signaling molecules within cells. Under normal …
(cGMP) have been recognized as important signaling molecules within cells. Under normal …
RNA adenosine modifications related to prognosis and immune infiltration in osteosarcoma
S Chen, J Zeng, L Huang, Y Peng, Z Yan… - Journal of Translational …, 2022 - Springer
Background RNA adenosine modifications, which are primarily mediated by “writer”
enzymes (RMWs), play a key role in epigenetic regulation in various biological processes …
enzymes (RMWs), play a key role in epigenetic regulation in various biological processes …
Cyclic nucleotide phosphodiesterases: important signaling modulators and therapeutic targets
F Ahmad, T Murata, K Shimizu, E Degerman… - Oral …, 2015 - Wiley Online Library
By catalyzing hydrolysis of cyclic adenosine monophosphate (cAMP) and cyclic guanosine
monophosphate (cGMP), cyclic nucleotide phosphodiesterases are critical regulators of their …
monophosphate (cGMP), cyclic nucleotide phosphodiesterases are critical regulators of their …
Targeting cancer with phosphodiesterase inhibitors
R Savai, SS Pullamsetti, GA Banat… - Expert opinion on …, 2010 - Taylor & Francis
Importance of the field: For many cancers, there has been a shift from management with
traditional, nonspecific cytotoxic chemotherapies to treatment with molecule-specific …
traditional, nonspecific cytotoxic chemotherapies to treatment with molecule-specific …
Guanylate cyclase-C as a therapeutic target in gastrointestinal disorders
SA Waldman, M Camilleri - Gut, 2018 - gut.bmj.com
Functional gastrointestinal disorders (FGIDs) and IBDs are two of the most prevalent
disorders of the GI tract and consume a significant proportion of healthcare resources …
disorders of the GI tract and consume a significant proportion of healthcare resources …
Uroguanylin and guanylin peptides: pharmacology and experimental therapeutics
LR Forte Jr - Pharmacology & therapeutics, 2004 - Elsevier
Guanylin, uroguanylin, and the bacterial heat-stable enterotoxin (ST) peptides comprise a
new family of cyclic guanosine 3′-5′ monophosphate (cGMP)-regulating agonists. The …
new family of cyclic guanosine 3′-5′ monophosphate (cGMP)-regulating agonists. The …
Regulation and therapeutic targeting of peptide-activated receptor guanylyl cyclases
LR Potter - Pharmacology & therapeutics, 2011 - Elsevier
Cyclic GMP is a ubiquitous second messenger that regulates a wide array of physiologic
processes such as blood pressure, long bone growth, intestinal fluid secretion …
processes such as blood pressure, long bone growth, intestinal fluid secretion …
Guanylyl cyclase C suppresses intestinal tumorigenesis by restricting proliferation and maintaining genomic integrity
P Li, S Schulz, A Bombonati, JP Palazzo, TM Hyslop… - Gastroenterology, 2007 - Elsevier
Background & Aims: The most commonly lost gene products in colorectal carcinogenesis
include guanylin and uroguanylin, endogenous ligands for guanylyl cyclase C (GCC) …
include guanylin and uroguanylin, endogenous ligands for guanylyl cyclase C (GCC) …